BenevolentAI : Letter to shareholders -December 27, 2023 at 05:36 am EST
Shareholder letter December 2023 Dear Shareholders AI is becoming an accepted and validated approach to drug discovery and development with...
Source: marketscreener.com
Page 2 - Benevolent Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Benevolent Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Benevolent Platform Today - Breaking & Trending Today
Artificial Intelligence (AI) in Drug Discovery Market Size & Share to Surpass $7.1 Billion by 2030
WASHINGTON, Nov. 06, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Global Artificial Intelligence in the Drug Discovery Market has been steadily growing over the years due to the growing demand for personalized medicine, the requirement for effective drug development procedures, and partnerships between pharmaceutical companies and AI technology providers. By analyzing enormous volumes of biological and chemical data, AI algorithms and data analytic approaches are revolutionizing
Source: yahoo.com
New Preclinical Data on AI-Generated Target Identified in BenevolentAI and AstraZeneca Collaboration Presented at ATS 2023
Research, presented by AstraZeneca, provides information on the biological validation of Serum Response Factor as a potential target for idiopathic pulmonary fibrosis The target was discovered
Source: finanznachrichten.de
BenevolentAI : 9xchange joins forces with BenevolentAI to integrate its AI technology into its innovative biopharma marketplace
Marketplace and partnership promote information sharing and collaboration across the biopharma industry to accelerate new drug discovery and development. ... | May 16, 2023
Source: marketscreener.com
BenevolentAI : Press release Result of Annual General Meeting
BenevolentAI Result of Annual General Meeting London, UK, 4 May 2023: BenevolentAI , a leading, clinical-stageAI-enabled drug discovery and... | May 4, 2023
Source: marketscreener.com